U.S. Chamber of Commerce Presents Masimo CEO Joe Kiani With Intellectual Property Champion Award

April 20, 2015

IRVINE, CA -- (Marketwired) -- 04/20/15 -- The U.S. Chamber of Commerce Global IP Center today presented Joe Kiani, founder, CEO and Chairman of the Board of Masimo (NASDAQ: MASI), with a 2015 IP Champion Award at a ceremony commemorating World IP Day in Washington, D.C.

Mr. Kiani has more than 65 patents in his name and more than 575 patents issued or filed by Masimo in medical technologies related to noninvasive patient monitoring. Mr. Kiani was selected for his pioneering work in life sciences, his prolific patent portfolio, his passion for innovation, and his advocacy for strong intellectual property protection in the United States and across the globe.

"From developing new lifesaving medical technologies, creating cures for terrible diseases, or making unsafe water safe for consumption, the individuals, businesses, and ideas honored today represent some of the very best examples of innovation from around the world," said David Hirschmann, president and CEO of GIPC. "Defining the true meaning of World IP Day, IP and innovation are the commonalities that all of today's awardees share, and GIPC looks forward to continuing to work with today's winners, government officials, and stakeholders around the world to promote and protect IP."

The Global IP Center noted that the U.S. economy is driven by the need to innovate, create, and develop new ways to serve consumers, and that intellectual property protection plays an essential role. When inventors, researchers, engineers, artists, and entrepreneurs know that their work will be protected and rewarded through strong IP rights -- including patents, trademarks, and copyrights -- they have the certainty and the incentive to keep the economy-boosting innovations coming.

"I am honored to receive this award," said Joe Kiani, founder and CEO of Masimo. "Innovation is not only vital for improving patients' lives but is also the cornerstone of our economy. My company was built on breakthrough innovations that not only made noninvasive pulse oximetry reliable, but made noninvasive monitoring of hemoglobin, carbon monoxide, and many other blood constituents possible. Without the promise of a strong IP system to defend our innovation, we wouldn't have been able to raise the more than $90 million in venture capital financing we needed to break even. However, to be a champion of innovation means so much more to me. In the middle of more than 100 billion galaxies each with billions of stars and all of the forces around us, innovation is crucial for the survival of the human race. To be on the side of a strong and deliberate IP system that fosters innovation, is to be on the right side of history."

The U.S. Chamber of Commerce created the Global Intellectual Property Center to meet the serious criminal and policy threats facing investors, IP-industries, and consumers. Today, the organization is leading a worldwide effort to champion intellectual property rights as vital to creating jobs, saving lives, advancing global economic growth, and generating breakthrough solutions to global challenges. For more information, please visit www.theglobalipcenter.com.



About Masimo:
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion™ pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at www.masimo.com.

Forward Looking Statements
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: whether Mr. Kiani's receipt of the 2015 IP Champion award will have any material effect on our business, as well as other factors discussed in the Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks or registered trademarks of Masimo.

Media Contact:
Mike Drummond
Masimo Corporation
Phone: (949) 297-7434
Email: mdrummond@masimo.com

Source: Masimo